Exercise could reduce bone tumor growth

May 7, 2013 by Anne Ju
Exercise could reduce bone tumor growth
3-D microCT reconstructions of control and tumor-injected tibiae, loaded and nonloaded. Credit: Fischbach lab

(Medical Xpress)—Weight-bearing exercise, often prescribed to combat bone loss, might have anti-cancer effects. Cornell biomedical researchers report that mechanical stimulation of cancerous bone, in making bone stronger, seems to make tumors weaker.

The study, which involved both animal and in vitro models, showed that causing bone to bear moderate, repeated weight – akin to an – led to inhibited growth of bone tumors composed of metastasized breast cancer cells. The researchers think that such might reduce the expression of genes that interfere with normal, healthy bone functioning.

Published online May 3 by the Journal of Bone and Mineral Research, the study was led by first author and Maureen Lynch and senior author Claudia Fischbach-Teschl, associate professor of biomedical engineering.

Breast cancer often metastasizes to bone, which then deteriorates because a tumor disturbs the normal process of bone remodeling. The subsequent bone loss, which is caused by too much known as osteolysis, helps feed the tumor, because the bone is a depot of factors that promote . Degraded bone releases these stored factors, and the tumor grows.

The researchers used a bone "loading model" to show that tumors respond to mechanical stimulation. The loading model originated in the lab of paper co-author Marjolein van der Meulen, the Swanson Professor of Biomedical Engineering at Cornell, who studies biological mechanics particularly in bone.

The experiments showed that loading of a mouse tibia injected with malignant – recreating the metastatic condition – kept the tumor from growing and increased bone mass. Doing nothing allowed the tumor to proliferate and the bone to degrade.

Exercise could reduce bone tumor growth
Corresponding histologic cross-sections of tibiae that reveal that nonloaded tumor-bearing tibiae exhibit osteolytic degradation and extensive tumor formation, whereas loading inhibited these changes. Credit: Fischbach lab

"If you think about typical cancer treatment, like chemotherapies, they are targeting the cancer cells," Lynch said. "So we needed to figure out if loading is affecting the tumor cells in addition to the bone cells, or if this is some kind of indirect effect. We found a little bit of both."

To control microenvironmental factors, the researchers did other experiments with a 3-D tumor model designed in Fischbach-Teschl's lab. They injected tumor cells into a porous scaffold that looks like an aspirin pill, then loaded the cells by using a piston to squeeze the scaffold. They examined how different genes characteristic of tumor cells were expressed as the loading occurred.

Genes involved in cancer were largely unaffected, except one, called Runx2, a transcription factor that regulates gene expression and production of other proteins. This, in turn, affects what bone cells are doing.

In a cancer cell, the researchers have theorized, Runx2 directs the cells to secrete proteins that stimulate osteolysis, too much of which leads to bone loss. Mechanical loading inhibits expression of Runx2, and they think that's why proteins that affect osteolysis are also reduced. Further experimentation to confirm this theory is needed.

The insights from this paper could lead not only to drug therapies but also to more targeted exercise regimens for cancer patients, Fischbach-Teschl said.

"Specifically, physically mediated mechanisms in bone might be contributing to bone loss in cancer patients," she said. "So harnessing those things better is what could really help patients."

The paper is titled "In Vivo Tibial Compression Decreases Osteolysis and Tumor Formation in Human Metastatic Model."

Explore further: Heparin-like compounds inhibit breast cancer metastasis to bone

More information: onlinelibrary.wiley.com/doi/10 … jbmr.1966/references

Related Stories

Heparin-like compounds inhibit breast cancer metastasis to bone

May 21, 2012
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a ...

'Fertilizing' bone marrow helps answer why some cancers spread to bones

May 15, 2012
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.